AGIO vs BAC Stock Comparison
BAC currently leads AGIO in this stock comparison, with AIQ scores of 58 vs 56. The clearest difference is risk resilience, while AGIO has the stronger momentum profile.
What is the main difference between AGIO and BAC?
BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Agios Pharmaceuticals, Inc. vs Bank of America Corporation
BAC leads
BAC leads by 2 AIQ points, primarily on Risk Resilience and Value, but the lead has narrowed from 13 points over 30 sessions.
Fragile: 3 of 6 evidence groups support BAC, its lead is narrowing, and its current signal state is conflicted.
Agios Pharmaceuticals, Inc.
Bank of America Corporation
The Algovestiq AIQ Score currently favors BAC over AGIO, 58 versus 56 as of Nov 15, 2026. BAC's advantage is driven primarily by stronger risk resilience and value, while AGIO holds the stronger momentum profile. BAC also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. BAC lead: Weakening — the AIQ differential moved from 13 to 2 points over 30 sessions.
Compare Agios Pharmaceuticals, Inc. and Bank of America Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AGIO and BAC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience47 vs 83BAC +36
- Momentum61 vs 37AGIO +24
- Value52 vs 68BAC +16
- Quality58 vs 64BAC +6
3 of 6 evidence groups favor BAC. BAC’s edge is concentrated in risk resilience and value; AGIO keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality +1, not enough on its own to move the overall score.
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.30x)
No factor moved materially.
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
BAC's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AGIO and BAC both carry a full feed there.
The central trade-off
BAC (Bank of America Corporation): the stronger current systematic profile, led by risk resilience and value.
AGIO (Agios Pharmaceuticals, Inc.): the counter-case, on momentum, fundamentals, technicals — but at materially higher volatility, 96.3% against 24.8%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BACBAC on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AGIOAGIO on combined revenue and EPS growth.
Value
BACBAC on the peer-relative Value factor, by 16 points.
Momentum
AGIOAGIO on the Momentum factor, by 24 points.
Lower downside
BACBAC on Risk Resilience, by 36 points.
Analyst upside
BACBAC on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AGIO | BAC | Note |
|---|---|---|---|
| Implied upside to target | +10.8% | +24.1% | BAC has more room |
| Target dispersion | 0% | +25.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 10 | 25 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 56 vs 58 |
| Fundamentals | AGIOon balance | revenue growth 23.8% vs -3.3%; EPS growth 35.5% vs -23.8%; TTM ROE -6.6% vs 2.3%; gross margin 91.9% vs 60.4%; operating margin -297.7% vs 22.4% — AGIO takes 3 of 5 decided legs, not all of them |
| Valuation | BAC | Value 52 vs 68 |
| Technicals | AGIO | Price vs 50-day -4.5% vs -5.6%; vs 200-day -0.8% vs -7% |
| Risk Resilience | BAC | Risk Resilience 47 vs 83 |
| Analyst expectations | BAC | Target upside 10.8% vs 24.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AGIO and BAC and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.
How the comparison changed
120 daily snapshots · May 27 – Nov 13BAC lead: Weakening — the AIQ differential moved from 13 to 2 points over 30 sessions.
- Today
- BAC +2
- 56 vs 58
- 7 sessions ago
- BAC +1
- 57 vs 58
- 30 sessions ago
- BAC +13
- 49 vs 62
- 90 sessions ago
- BAC +13
- 58 vs 71
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 2 neutral, conflicted
Only AGIO
- Golden Cross Active — bullish, trend, long horizon (3.90%)
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.84%)
- Beta Spike Warning — bearish, risk_regime, long horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.30x)
2 bullish / 2 bearish / 1 neutral, conflicted
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
- Death Cross Active — bearish, trend, long horizon (1.45%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
BAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.54%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AGIO closes the Risk Resilience gap — currently 36 points behind, the largest single contributor to BAC's edge.
- 2AGIO's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 11 points over 30 sessions, and a further 2-point move would eliminate BAC's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AGIO leads on balance| Metric | AGIO | BAC |
|---|---|---|
| Revenue growth (YoY) | 23.8% | -3.3% |
| EPS growth (YoY) | 35.5% | -23.8% |
| Gross margin | 91.9% | 60.4% |
| Operating margin | -297.7% | 22.4% |
| Return on equity (TTM) | -6.6% | 2.3% |
| Debt to equity | 0.03 | 1.28 |
Performance
AGIO leads 5 of 6 windows| Metric | AGIO | BAC |
|---|---|---|
| 1 week (5 sessions) | 7.4% | 3.2% |
| 1 month (20 sessions) | 0.9% | -0.4% |
| 3 months (63 sessions) | -6.1% | -20.1% |
| 6 months (126 sessions) | 12.1% | 2.5% |
| Year to date | 16.1% | -7.2% |
| 1 year (252 sessions) | -27.6% | -5.7% |
Technicals
AGIO has the stronger structure| Metric | AGIO | BAC |
|---|---|---|
| RSI (14) | 46.3 | 45.9 |
| ADX (14) | 20.6 | 27.2 |
| Price vs 50-day | -4.5% | -5.6% |
| Price vs 200-day | -0.8% | -7% |
| Volatility (1M, annualized) | 96.3% | 24.8% |
Risk
BAC is the more resilient| Metric | AGIO | BAC |
|---|---|---|
| Beta | 0.93 | 0.79 |
| Sharpe ratio | 0.07 | -0.22 |
| Sortino ratio | 0.08 | -0.29 |
| Max drawdown | -50.9% | -23.7% |
| Current drawdown | -30.6% | -21.3% |
| Annualized volatility | 80% | 22.4% |
| Value at risk (95%) | -3.9% | -2.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AGIO or BAC?
On the Algovestiq AIQ Score, BAC is the stronger of the two as of Nov 15, 2026, scoring 58 against AGIO's 56. The edge comes from risk resilience and value. AGIO is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AGIO or BAC the better buy right now?
BAC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.
Why does the AIQ Score favor BAC over AGIO?
The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 36 points; AGIO leads Momentum by 24 points; BAC leads Value by 16 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AGIO or BAC?
Analyst price targets imply +10.8% upside for AGIO and +24.1% for BAC, so the Street currently favors BAC. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AGIO or BAC?
BAC is the better-valued of the two on the peer-relative Value factor. BAC on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AGIO or BAC?
AGIO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AGIO or BAC?
AGIO on the Momentum factor, by 24 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AGIO or BAC?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 36 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AGIO more profitable than BAC?
The profitability evidence is mixed: gross margin 91.9% vs 60.4%; operating margin -297.7% vs 22.4%; ttm roe -6.6% vs 2.3%. AGIO leads on one measure and BAC on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is BAC's lead over AGIO getting stronger or weaker?
BAC lead: Weakening — the AIQ differential moved from 13 to 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the AGIO vs BAC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AGIO closes the Risk Resilience gap — currently 36 points behind, the largest single contributor to BAC's edge; AGIO's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 11 points over 30 sessions, and a further 2-point move would eliminate BAC's advantage entirely.
What do the current signals say about AGIO and BAC?
AGIO: 1 bullish / 2 bearish / 2 neutral, conflicted. BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AGIO is Golden Cross Active (bullish, long horizon). On BAC it is Death Cross Active (bearish, long horizon).
Compare AGIO and BAC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.